← Leaderboards
Jonathan Sterne
University Of Bristol
$2,069,103
Attributed
$2,721,218
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $494.6K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,721,218 · 2
By mechanism
U01$1,743,046 · 1
R01$978,172 · 1
Top collaborators
- Suzanne Ingle2 shared
- Adam Trickey2 shared
Most similar at University Of Bristol
Same institution · by research overlap
- Suzanne Ingle$326,057
- Adam Trickey$326,057
- Margaret May$456,829
Others in their field
Other Emerging Leaders on “Aging”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$64,693,871
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,272,240
- Abraham Aizer Brody · New York University School Of Medicine$23,963,022
Research focus
AgingAntiretroviral TherapyData SetEuropeHospitalizationMortalityCollaborationsData ExchangeStandardizationNorth AmericaUnited States National Institutes Of HealthUpdateCohortCohort StudiesAdultCaringCountryWomanData SharingPublic Health RelevanceCocaineAlcohol MeasurementAlcohol InterventionBiological Markers
Grant awards (6)
A secure analytics platform to study the prognosis of people with HIV in the USA, Canada and Europe and comparative effectiveness of treatment regimens: the Antiretroviral Therapy Cohort Collaboration$483,540
R01 · FY2025 · AI · contact PI
A secure analytics platform to study the prognosis of people with HIV in the USA, Canada and Europe and comparative effectiveness of treatment regimens: the Antiretroviral Therapy Cohort Collaboration$494,632
R01 · FY2024 · AI · contact PI
1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA$427,571
U01 · FY2021 · AA · contact PI
1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA$436,675
U01 · FY2020 · AA · contact PI
1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA$444,976
U01 · FY2019 · AA · contact PI
1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA$433,824
U01 · FY2018 · AA · contact PI